Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Subcellular Localization and Activity of the Mitogen-activated Protein Kinase Kinase 7 (MKK7) γ Isoform are Regulated through Binding to the Phosphatase Calcineurin.

Gibson ES, Woolfrey KM, Li H, Hogan PG, Nemenoff RA, Heasley LE, Dell'Acqua ML.

Mol Pharmacol. 2018 Nov 7. pii: mol.118.113159. doi: 10.1124/mol.118.113159. [Epub ahead of print]

2.

L-Type Voltage-Gated Ca2+ Channels Regulate Synaptic-Activity-Triggered Recycling Endosome Fusion in Neuronal Dendrites.

Hiester BG, Bourke AM, Sinnen BL, Cook SG, Gibson ES, Smith KR, Kennedy MJ.

Cell Rep. 2017 Nov 21;21(8):2134-2146. doi: 10.1016/j.celrep.2017.10.105.

3.

Solid-binding peptides for immobilisation of thermostable enzymes to hydrolyse biomass polysaccharides.

Care A, Petroll K, Gibson ESY, Bergquist PL, Sunna A.

Biotechnol Biofuels. 2017 Feb 2;10:29. doi: 10.1186/s13068-017-0715-2. eCollection 2017.

4.

Optogenetic Control of Synaptic Composition and Function.

Sinnen BL, Bowen AB, Forte JS, Hiester BG, Crosby KC, Gibson ES, Dell'Acqua ML, Kennedy MJ.

Neuron. 2017 Feb 8;93(3):646-660.e5. doi: 10.1016/j.neuron.2016.12.037. Epub 2017 Jan 26.

5.

Local and Use-Dependent Effects of β-Amyloid Oligomers on NMDA Receptor Function Revealed by Optical Quantal Analysis.

Sinnen BL, Bowen AB, Gibson ES, Kennedy MJ.

J Neurosci. 2016 Nov 9;36(45):11532-11543.

6.

Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss.

Freund RK, Gibson ES, Potter H, Dell'Acqua ML.

Mol Pharmacol. 2016 May;89(5):552-9. doi: 10.1124/mol.115.103085. Epub 2016 Mar 8.

7.

A light-triggered protein secretion system.

Chen D, Gibson ES, Kennedy MJ.

J Cell Biol. 2013 May 13;201(4):631-40. doi: 10.1083/jcb.201210119.

8.

AKAP150-anchored calcineurin regulates synaptic plasticity by limiting synaptic incorporation of Ca2+-permeable AMPA receptors.

Sanderson JL, Gorski JA, Gibson ES, Lam P, Freund RK, Chick WS, Dell'Acqua ML.

J Neurosci. 2012 Oct 24;32(43):15036-52. doi: 10.1523/JNEUROSCI.3326-12.2012.

9.

Palmitoylation of A-kinase anchoring protein 79/150 regulates dendritic endosomal targeting and synaptic plasticity mechanisms.

Keith DJ, Sanderson JL, Gibson ES, Woolfrey KM, Robertson HR, Olszewski K, Kang R, El-Husseini A, Dell'acqua ML.

J Neurosci. 2012 May 23;32(21):7119-36. doi: 10.1523/JNEUROSCI.0784-12.2012.

10.

Phosphorylation regulates removal of synaptic N-methyl-D-aspartate receptors after withdrawal from chronic ethanol exposure.

Clapp P, Gibson ES, Dell'acqua ML, Hoffman PL.

J Pharmacol Exp Ther. 2010 Mar;332(3):720-9. doi: 10.1124/jpet.109.158741. Epub 2009 Dec 14.

11.

Regulation of postsynaptic structure and function by an A-kinase anchoring protein-membrane-associated guanylate kinase scaffolding complex.

Robertson HR, Gibson ES, Benke TA, Dell'Acqua ML.

J Neurosci. 2009 Jun 17;29(24):7929-43. doi: 10.1523/JNEUROSCI.6093-08.2009.

12.

Departments of corrections as purchasers of community-based treatment: a national study.

Kubiak SP, Arfken CL, Gibson ES.

J Subst Abuse Treat. 2009 Jun;36(4):420-7. doi: 10.1016/j.jsat.2008.08.009. Epub 2008 Nov 11.

PMID:
19004602
13.

"Sleepiness" is serious in adolescence: two surveys of 3235 Canadian students.

Gibson ES, Powles AC, Thabane L, O'Brien S, Molnar DS, Trajanovic N, Ogilvie R, Shapiro C, Yan M, Chilcott-Tanser L.

BMC Public Health. 2006 May 2;6:116.

15.

Regulation of neuronal PKA signaling through AKAP targeting dynamics.

Dell'Acqua ML, Smith KE, Gorski JA, Horne EA, Gibson ES, Gomez LL.

Eur J Cell Biol. 2006 Jul;85(7):627-33. Epub 2006 Feb 28. Review.

PMID:
16504338
16.

Synthesis of a novel C-nucleoside, 2-amino-7-(2-deoxy-beta-D-erythro- pentofuranosyl)-3H,5H-pyrrolo-[3,2-d]pyrimidin-4-one (2'-deoxy-9-deazaguanosine).

Gibson ES, Lesiak K, Watanabe KA, Gudas LJ, Pankiewicz KW.

Nucleosides Nucleotides. 1999 Mar;18(3):363-76.

PMID:
10358941
17.
18.
19.

Lung cancer and air pollution in an industrial city--a geographical analysis.

Shannon HS, Hertzman C, Julian JA, Hayes MV, Henry N, Charters J, Cunningham I, Gibson ES, Sackett DL.

Can J Public Health. 1988 Jul-Aug;79(4):255-9. No abstract available.

PMID:
3167749
20.

The value of preplacement screening radiography of the low back.

Gibson ES.

Occup Med. 1988 Jan-Mar;3(1):91-107. Review.

PMID:
2963395
21.

The mutagenicity of emissions from eight binder systems used in steel foundries.

Kaiser-Farrell C, Sheldrake C, McCalla DR, Gibson ES, Kerr AA, Lockington JN.

Am Ind Hyg Assoc J. 1986 Sep;47(9):578-86.

PMID:
3532748
22.

The company doctor: an endangered species.

Gibson ES.

Can Fam Physician. 1985 Oct;31:1935-8.

23.

Identification of polycyclic aromatic compounds in mutagenic emissions from steel casting.

Quilliam MA, Lant MS, Kaiser-Farrell C, McCalla DR, Sheldrake CP, Kerr AA, Lockington JN, Gibson ES.

Biomed Mass Spectrom. 1985 Apr;12(4):143-50.

PMID:
3160400
24.

Effects of labelling on income, work and social function among hypertensive employees.

Johnston ME, Gibson ES, Terry CW, Haynes RB, Taylor DW, Gafni A, Sicurella JI, Sackett DL.

J Chronic Dis. 1984;37(6):417-23.

PMID:
6725496
25.

Lung cancer in a steel foundry: a search for causation.

Gibson ES, McCalla DR, Kaiser-Farrell C, Kerr AA, Lockington JN, Hertzman C, Rosenfeld JM.

J Occup Med. 1983 Aug;25(8):573-8.

PMID:
6886864
26.

Distribution of extractable mutagenic activity in steel foundry air particulates of different sizes.

McCalla DR, Kaiser-Farrell C, Kerr A, Lockington JN, Gibson ES.

Environ Mutagen. 1983;5(6):881-9.

PMID:
6653507
27.

Is there a trade-off between income and health? The case of hypertensive steelworkers in Canada.

Gafni A, Gibson ES, Johnston M, Haynes RB, Taylor DW, Terry CW, Sackett DL.

Inquiry. 1983 Winter;20(4):343-9.

PMID:
6229485
28.

Process versus outcome in hypertension: a positive result.

Haynes RB, Gibson ES, Taylor DW, Bernholz CD, Sackett DL.

Circulation. 1982 Jan;65(1):28-33.

PMID:
7053286
29.

Longterm follow-up of absenteeism among working men following the detection and treatment of their hypertension.

Taylor DW, Haynes RB, Sackett DL, Gibson ES.

Clin Invest Med. 1981;4(3-4):173-7. No abstract available.

PMID:
7337988
30.

Can simple clinical measurements detect patient noncompliance?

Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J.

Hypertension. 1980 Nov-Dec;2(6):757-64.

PMID:
7007235
31.

Incidence of low back pain and pre-placement x-ray screening.

Gibson ES, Martin RH, Terry CW.

J Occup Med. 1980 Aug;22(8):515-9.

PMID:
6447197
32.

Increased absenteeism from work after detection and labeling of hypertensive patients.

Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL.

N Engl J Med. 1978 Oct 5;299(14):741-4.

PMID:
692548
33.

Compliance with antihypertensive drug therapy.

Taylor DW, Sackett DL, Haynes RB, Johnson AL, Gibson ES, Roberts RS.

Ann N Y Acad Sci. 1978 Mar 30;304:390-403. Review. No abstract available.

PMID:
360927
34.

Patient compliance with antihypertensive regimens.

Sackett DL, Haynes RB, Gibson ES, Taylor DW, Roberts RS, Johnson AL.

Patient Couns Health Educ. 1978 1st Quart;1(1):18-21. No abstract available.

PMID:
10238880
35.

Lung cancer mortality in a stell foundry.

Gibson ES, Martin RH, Lockington JN.

J Occup Med. 1977 Dec;19(12):807-12. No abstract available.

PMID:
592002
36.

Normative standards of plasma cholesterol and triglyceride concentrations in Canadians of working age.

Hewitt D, Jones GJ, Godin GJ, McComb K, Breckenridge WC, Little JA, Steiner G, Mishkel MA, Baillie JH, Martin RH, Gibson ES, Prendergast WF, Parliament WJ.

Can Med Assoc J. 1977 Nov 5;117(9):1020-4.

37.

Hypertension control, compliance and science.

Sackett DL, Haynes RB, Gibson ES, Taylor DW, Roberts RS, Johnson AL.

Am Heart J. 1977 Nov;94(5):666-7. No abstract available.

PMID:
910705
38.

Improvement of medication compliance in uncontrolled hypertension.

Haynes RB, Sackett DL, Gibson ES, Taylor DW, Hackett BC, Roberts RS, Johnson AL.

Lancet. 1976 Jun 12;1(7972):1265-8.

PMID:
73694
39.

Mortality and morbidity in an employed population.

Gibson ES, Martin RH, Haynes RB.

Can Fam Physician. 1976 Mar;22:81-90.

40.

Vascular diseases in employed males: a perspective on preventive and remedial programs in industry.

Gibson ES, Haynes RB, Martin RH.

J Occup Med. 1975 Jul;17(7):425-9.

PMID:
1167247
41.

Randomised clinical trial of strategies for improving medication compliance in primary hypertension.

Sackett DL, Haynes RB, Gibson ES, Hackett BC, Taylor DW, Roberts RS, Johnson AL.

Lancet. 1975 May 31;1(7918):1205-7.

PMID:
48832
42.

Occupational hearing loss between 85 and 90 dBA.

Martin RH, Gibson ES, Lockington JN.

J Occup Med. 1975 Jan;17(1):13-8. No abstract available.

PMID:
1123674

Supplemental Content

Loading ...
Support Center